Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: Modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level

Neurochemistry International

Volumn 63, Issue 5, 2013, Pages 465-475

  Jindal, Ankur ^a   Mahesh, Radhakrishnan ^a   Bhatt, Shvetank ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

BDNF; CUMS; Depression; Etazolate; HPA axis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; ETAZOLATE; FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTABLE MILD STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILITY; LOCOMOTION; MAZE TEST; MOBILIZATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TAIL SUSPENSION TEST; TRANQUILIZING ACTIVITY;

MUS; RODENTIA;

BDNF; CUMS; DEPRESSION; ETAZOLATE; HPA AXIS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; ETAZOLATE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL;

EID: 84883550342     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.08.005     Document Type: Article

References (124)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders fourth ed. 1994 APA Press Washington DC (DSM-IV)
2. I.L. Andersen, K.E. Boe, G. Foerevik, A.M. Janczak, and M. Bakken Behavioral evaluation of methods for assessing fear responses in weaned pigs Appl. Anim. Behav. Sci. 69 2000 227 240 (Pubitemid 30622730)
3. H. Anisman, and R.M. Zacharko Depression: the predisposing influence of stress Behav. Brain Sci. 5 1982 89 137
4. C. Aydemir, E.S. Yalcin, S. Aksaray, C. Kisa, S.G. Yildirim, T. Uzbay, and E. Goka Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 1256 1260 (Pubitemid 44216065)
5. O. Aydemir, A. Deveci, O.E. Taskin, F. Taneli, and A. Esen-Danaci Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 1023 1026 (Pubitemid 46810091)
6. J.C. Ballenger Clinical guidelines for establishing remission in patients with depression and anxiety J. Clin. Psychiatry 60 1999 29 34 (Pubitemid 30107953)
7. A.D. Başterzi, K. Yazici, E. Aslan, N. Delialioǧlu, B. Taşdelen, S. Tot Acar, and A. Yazici Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 281 285
8. B. Beer, M. Chasin, D.E. Clody, and J.R. Vogel Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety Science 176 1972 428 430
9. S. Bekris, K. Antoniou, S. Daskas, and Z. Papadopoulou-Daifoti Behavioral and neurochemical effects induced by chronic mild stress applied to two different rat strains Behav. Brain Res. 161 2005 45 59 (Pubitemid 40719769)
10. C. Belzung, and G. Griebel Measuring normal and pathological anxiety-like behavior in mice: a review Behav. Brain Res. 125 2001 141 149 (Pubitemid 33000452)
11. C. Belzung, and G. Le Pape Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety Physiol. Behav. 56 1994 623 628 (Pubitemid 24269590)
12. G. Biala, and M. Kruk Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 54 61
13. C. Bielajew, A.T.M. Konke, and Z. Merali The effects of chronic mild stress on male SpragueDawley and Long Evans rats: I. Biochemical and physiological analyses Behav. Brain Res. 136 2002 583 592 (Pubitemid 35333273)
14. J.R. Boissier, and P. Simon Action of caffeine on the spontaneous motility of the mouse Arch. Int. Pharmacodyn. Ther. 158 1965 212 221
15. C.O. Bondi, G. Rodriguez, G.G. Gould, A. Frazer, and D.A. Morilak Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment Neuropsychopharmacology 33 2008 320 331 (Pubitemid 350243351)
16. F. Borsini, J. Podhorna, and D. Marazziti Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology 163 2002 121 141 (Pubitemid 35013604)
17. E.S. Buhl, T.K. Jensen, N. Jessen, B. Elfving, C.S. Buhl, S.B. Kristiansen, R. Pold, L. Solskov, O. Schmitz, G. Wegener, S. Lund, and K.F. Petersen Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats Am. J. Physiol. Endocrinol. Metab. 298 2010 E920 E929
18. F. Calabrese, R. Molteni, G. Racagni, and M.A. Riva Neuronal plasticity: a link between stress and mood disorders Psychoneuroendocrinology 34 2009 S208 S216
19. R.J. Carey, G. DePalma, and E. Damianopoulos Cocaine-conditioned behavioral effects: a role for habituation processes Pharmacol. Biochem. Behav. 74 2003 701 712 (Pubitemid 36126549)
20. E. Castrén, V. Võikarm, and T. Rantamäki Role of neurotrophic factors in depression Curr. Opin. Pharmacol. 7 2007 18 21 (Pubitemid 46238033)
21. J. Charoenphandhu, J. Teerapornpuntakit, A. Nuntapornsak, N. Krishnamra, and N. Charoenphandhu Anxiety-like behaviors and expression of SERT and TPH in the dorsal raphé of estrogen- and fluoxetine-treated ovariectomized rats Pharmacol. Biochem. Behav. 98 2011 503 510
22. M. Chasin, D.N. Harris, M.B. Phillips, and S.M. Hess 1-Ethyl-4- (isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)-a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterases Biochem. Pharmacol. 21 1972 2443 2450
23. Y. Chen, H.D. Wang, X. Xia, H.F. Kung, Y. Pan, and L.D. Kong Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice Phytomedicine 14 2007 523 529 (Pubitemid 47068943)
24. X. Chen, M. Li, W. Sun, Y. Bi, M. Cai, H. Liang, Q. Yu, X. He, and J. Weng Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats Biochem. Biophys. Res. Commun. 368 2008 865 870
25. S. Chiba, T. Numakawa, M. Ninomiya, M.C. Richards, C. Wakabayashi, and H. Kunugi Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex Prog. Neuropsychopharmacol. Biol. Psychiatry 39 2012 112 119
26. J.W. Daly, O. Hong, W.L. Padgett, M.T. Shamim, Jacobson, and D. Ukena Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors Biochem. Pharmacol. 37 1988 655 664
27. P.S. D'Aquila, P. Brain, and P. Willner Effects of chronic mild stress on performance in behavioral tests relevant to anxiety and depression Physiol. Behav. 56 1994 861 867 (Pubitemid 24337098)
28. E.R. De Kloet, M. Joels, and F. Holsboer Stress and the brain: from adaptation to disease Nat. Rev. Neurosci. 6 2005 463 475 (Pubitemid 40769171)
29. C.M. Dording, D. Mischoulon, T.J. Petersen, R. Kornblum, J. Gordon, A.A. Nierenberg, J.E. Rosenbaum, and M. Fava The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists Ann. Clin. Psychiatry 14 2002 143 147 (Pubitemid 36172562)
30. R. Doron, D. Lotan, A. Rak-Rabl, A. Raskin-Ramot, K. Lavi, and M. Rehavi Anxiolytic effects of a novel herbal treatment in mice models of anxiety Life Sci. 90 2012 995 1000
31. J. Drott, L. Desire, D. Drouin, M. Pando, and F. Haun Etazolate improves performance in a foraging and homing task in aged rats Eur. J. Pharmacol. 634 2010 95 100
32. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotrophin releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 625 631 (Pubitemid 36645063)
33. S.C. Dulawa, D.K. Grandy, M.J. Low, M.P. Paulus, and M.A. Geyer Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli J. Neurosci. 19 1999 9550 9556 (Pubitemid 30228106)
34. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
35. R.S. Duman, J. Malberg, S. Nakagawa, and C. D'Sa Neuronal plasticity and survival in mood disorders Biol. Psychiatry 48 2000 732 739
36. L.S. Garcia, C.M. Comim, S.S. Valvassori, G.Z. Réus, L. Stertz, F. Kapczinski, E.C. Gavioli, and J. Quevedo Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 450 455
37. B. Gong, O.V. Vitolo, F. Trinchese, S. Liu, M. Shelanski, and O. Arancio Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment J. Clin. Invest. 114 2004 1624 1634 (Pubitemid 40385553)
38. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, T. Ben-Hur, and R. Yirmiya Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol. Psychiatry 13 2008 717 728 (Pubitemid 351861529)
39. J.Y. Guo, C.Y. Li, Y.P. Ruan, M. Sun, X.L. Qi, B.S. Zhao, and F. Luo Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain Eur. J. Pharmacol. 612 2009 54 60
40. B. Haenisch, A. Bilkei-Gorzo, M.G. Caron, and H. Bönisch Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression J. Neurochem. 111 2009 403 416
41. I. Hageman, M. Nielsen, G. Wortwein, N.H. Diemer, and M.B. Jorgensen Electroconvulsive stimulations normalizes stress-induced changes in the glucocorticoid receptor and behaviour Behav. Brain Res. 196 2009 71 77
42. B.L. Hankin Adolescent depression: description, causes, and interventions Epilepsy Behav. 8 2006 102 114 (Pubitemid 43103838)
43. A.C. Hansson, W.H. Sommer, M. Metsis, I. Stromberg, L.F. Agnati, and K. Fuxe Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter J. Neuroendocrinol. 18 2006 104 114
44. A. Hayashi, T. Kasahara, M. Kametani, and T. Kato Attenuated BDNF-induced upregulation of GABAergic markers in neurons lacking Xbp1 Biochem. Biophys. Res. Commun. 376 2008 758 763
45. R.B. Hidalgo, and J.R.T. Davidson Selective serotonin reuptake inhibitors in post-traumatic stress disorder J. Psychopharmacol. 14 2000 70 76 (Pubitemid 30156542)
46. S. Hogg A review of the validity and variability of the elevated plusmaze as an animal model of anxiety Pharmacol. Biochem. Behav. 54 1996 21 30 (Pubitemid 26146661)
47. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
48. Z.P. Horovitz, B. Beer, D.E. Clody, J.R. Vogel, and M. Chasin Cyclic AMP and anxiety Psychomatics 13 1972 85 92
49. M.D. Houslay PDE4 cAMP-specific phosphodiesterases Prog. Nucleic Acid Res. Mol. Biol. 69 2001 249 315 (Pubitemid 33805840)
50. T.N. Huynh, A.M. Krigbaum, J.J. Hanna, and C.D. Conrad Sex differences and phase of light cycle modify chronic stress effects on anxiety and depressive-like behavior Behav. Brain Res. 222 2011 212 222
51. A. Jindal, R. Mahesh, B. Gautam, S. Bhatt, and D. Pandey Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor - an approach using rodent behavioral antidepressant tests battery Eur. J. Pharmacol. 689 2012 125 131
52. A. Jindal, R. Mahesh, and S. Bhatt Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage Pharmacol. Biochem. Behav. 105 2013 63 70
53. A. Jindal, R. Mahesh, and S. Bhatt Anxiolytic-like effect of etazolate, a type 4 phosphodiesterase inhibitor in experimental models of anxiety Indian J. Exp. Bio. 51 2013 444 449
54. S.A. Johnson, N.M. Fournier, and L.E. Kalynchuk Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor Behav. Brain Res. 2 2006 280 288 (Pubitemid 43201945)
55. F. Karege, M. Schwald, and M. Cisse Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets Neurosci. Lett. 328 2002 261 264 (Pubitemid 34876661)
56. F. Karege, G. Vaudan, M. Schwald, N. Perroud, and R. La Harpe Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs Mol. Brain Res. 136 2005 29 37 (Pubitemid 40704606)
57. R.J. Katz, K.A. Roth, and B.J. Carroll Acute and chronic stress effects on open field activity in the rat: implications for a model of depression Neurosci. Biobehav. Rev. 5 1981 247 251 (Pubitemid 11074538)
58. A.J. Keeney, and S. Hogg Behavioural consequences of repeated social defeat in the mouse:preliminary evaluation of a potential animal model of depression Behav. Pharmacol. 10 1999 753 764 (Pubitemid 30028750)
59. K.S. Kendler, L.M. Karkowski, and C.A. Prescott Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity J. Nerv. Ment. Dis. 186 1998 661 669 (Pubitemid 29103863)
60. K.S. Kendler, L.M. Karkowski, and C.A. Prescott Causal relationship between stressful life events and the onset of major depression Am. J. Psychiatry 156 1999 837 841 (Pubitemid 29260336)
61. A. Klodzinska, E. Tatarczyńska, E. Chojnacka-Wójcik, G. Nowak, N.D. Cosford, and A. Pilc Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling Neuropharmacology 47 2004 42 50
62. H. Kompagne, G. Bardos, G. Szenasi, I. Gacsalyi, L.G. Harsing, and G. Levay Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats Behav. Brain Res. 193 2008 311 314
63. A.T. Konkle, S.L. Baker, A.C. Kentner, L.S. Barbagallo, Z. Merali, and C. Bielajew Evaluation of the effects of chronic mild stressors on hedonic and physiological responses: sex and strain compared Brain Res. 992 2003 227 238 (Pubitemid 37415105)
64. B. Kumar, A. Kuhad, and K. Chopra Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences Psychopharmacology (Berlin) 214 2011 819 828
65. H. Kunugi, H. Hori, N. Adachi, and T. Numakawa Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression Psychiatry Clin. Neurosci. 64 2010 447 459
66. M.H. Larsen, J.D. Mikkelsen, A. Hay-Schmidt, and C. Sandi Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment J. Psychiatr. Res. 44 2010 808 816
67. E.J. Lenze, R.C. Mantella, P. Shi, A.M. Goate, P. Nowotny, M.A. Butters, C. Andreescu, P.A. Thompson, and B.L. Rollman Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram Am. J. Geriatr. Psychiatry 19 2011 482 490
68. Y.F. Li, Y. Huang, S.L. Amsdell, L. Xiao, J.M. O'Donnell, and H.T. Zhang Antidepressant-and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus Neuropsychopharmacology 34 2009 2404 2419
69. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology 92 1987 180 185 (Pubitemid 17072893)
70. G. Lucca, C.M. Comim, S.S. Valvassori, J.G. Pereira, L. Stertz, E.C. Gavioli, F. Kapczinski, and J. Quevedo Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels Curr. Neurovasc. Res. 5 2008 207 213
71. M.A. Magariños, and B.S. McEwen Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons, involvement of glucocorticoid secretion and excitatory amino acid receptors Neuroscience 69 1995 89 98
72. M. Maillet, S.J. Robert, M. Cacquevel, M. Gastineau, D. Vivien, J. Bertoglio, J.L. Zugaza, R. Fischmeister, and F. Lezoualc'h Cross-talk between Rap1 and Rac regulates secretion of sAPP alpha Nat. Cell Biol. 5 2003 633 639 (Pubitemid 36818085)
73. H.K. Manji, and R.S. Duman Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics Psychopharmacol. Bull. 5 2001 35 49
74. R.C. Mantella, M.A. Butters, J.A. Amico, S. Mazumdar, B.L. Rollman, A.E. Begley, C.F. Reynolds, and E.J. Lenze Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder Psychoneuroendocrinology 33 2008 773 781
75. Q.Q. Mao, S.P. Ip, K.M. Ko, S.H. Tsai, and C.T. Che Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1211 1216
76. M. Marcade, J. Bourdin, N. Loiseau, H. Peillon, A. Rayer, D. Drouin, F. Schweighoffer, and L. Desire Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing J. Neurochem. 106 2008 392 404 (Pubitemid 351840218)
77. L.N. Maslova, V.V. Bulygina, and A.L. Markel Chronic stress during prepubertal development: immediate and long-lasting effects on arterial blood pressure and anxiety-related behavior Psychoneuroendocrinology 27 2002 549 561 (Pubitemid 34310617)
78. L. Matuszewich, J.J. Karney, S.R. Carter, S.P. Janasik, J.L. O'Brien, and R.D. Friedman The delayed effects of chronic unpredictable stress on anxiety measures Physiol. Behav. 90 2007 674 681 (Pubitemid 46329717)
79. B.S. McEwen Glucocorticoids, depression, and mood disorders: structural remodeling in the brain Metabolism 54 2005 20 23 (Pubitemid 40546018)
80. B.S. McEwen Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators Eur. J. Pharmacol. 583 2008 174 185
81. C.M. Middeldorp, M.C. Slof-Op't Landt, S.E. Medland, C.E. van Beijsterveldtm, M. Bartels, and G. Willemsen Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes? Genes Brain Behav. 9 2010 808 816
82. M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, A.E. de Freitas, M. Farina, and A.L. Severo Rodrigues Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress J. Psychiatr. Res. 46 2012 331 340
83. S.J. Moss, T.G. Smart, C.D. Blackstone, and R.L. Huganir Functional modulation of GABA receptors by cAMP-dependent protein phosphorylation Science 257 1992 661 665
84. S. Murakami, H. Imbe, Y. Morikawa, C. Kubo, and E. Senba Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly Neurosci. Res. 53 2005 129 139 (Pubitemid 41219528)
85. F. Murray, D.W. Smith, and P.H. Hutson Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice Eur. J. Pharmacol. 583 2008 115 127
86. G. Naert, G. Ixart, L. Tapia-Arancibia, and L. Givalois Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary- adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats Neuroscience 139 2006 779 789
87. C.B. Nemeroff The burden of severe depression: a review of diagnostic challenges and treatment alternatives J. Psychiatr. Res. 41 2007 189 206 (Pubitemid 44854991)
88. E.J. Nestler, M. Barrot, R.J. Dileone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25 (Pubitemid 34270695)
89. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J. Neurosci. 16 1996 2365 2372 (Pubitemid 26154346)
90. C.D. Nicholson, R.A. Challiss, and M. Shahid Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes Trends Pharmacol. Sci. 12 1991 19 27
91. J. Nirmal, C.S. Babu, T. Harisudhan, and M. Ramanathan Evaluation of behavioural and antioxidant activity of Cytisus scoparius Linn in rats exposed to chronic unpredictable mild stress BMC Complement Altern. Med. 8 2008 15
92. J.M. O'Donnell, and H.T. Zhang Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4) Trends Pharmacol. Sci. 25 2004 158 163 (Pubitemid 38264507)
93. W. Pan, W.A. Banks, M.B. Fasold, J. Bluth, and A.J. Kastin Transport of brain derived neurotrophic factor across the blood-brain barrier Neuropharmacology 37 1998 1553 1561 (Pubitemid 28550429)
94. S.B. Patten Confounding by severity and indication in observational studies of antidepressant effectiveness Can. J. Clin. Pharmacol. 15 2008 e367 e371
95. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arm entries in an elevated plus maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167 (Pubitemid 16239568)
96. D.G. Perahia, G. Maina, M.E. Thase, M.E. Spann, F. Wang, D.J. Walker, and M.J. Detke Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial J. Clin. Psychiatry 70 2009 706 716
97. W. Pitchot, G. Scantamburlo, E. Pinto, and M. Ansseau Recovering from depression: a matter of objective and determination Rev. Med. Liege. 65 2010 370 380
98. D.L. Pitman, J.E. Ottenweller, and B.H. Natelson Effect of intensity on habituation and sensitization of glucocorticoid responses in rats Behav. Neurosci. 104 1990 28 36 (Pubitemid 20138259)
99. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur. J. Pharmacol. 463 2003 3 33 (Pubitemid 36205070)
100. M. Ramanathan, B. Balaji, and A. Justin Behavioural and neurochemical evaluation of perment an herbal formulation in chronic unpredictable mild stress induced depressive model Indian J. Exp. Biol. 49 2011 269 275
101. R. Regenthal, H. Koch, C. Köhler, R. Preiss, and U. Krügel Depression-like deficits in rats improved by subchronic modafinil Psychopharmacology (BerlIN) 204 2009 627 639
102. A. Rex, J.P. Voigt, C. Gustedt, S. Beckett, and H. Fink Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test Psychopharmacology (Berlin) 177 2004 23 34 (Pubitemid 40109911)
103. R.J. Rodgers, and A. Dalvi Anxiety, defence and the elevated plus maze Neurosci. Biobehav. Rev. 21 1997 801 810 (Pubitemid 27524775)
104. R.M. Sapolsky, L.M. Romero, and A.U. Munck How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocr. Rev. 21 2000 55 89 (Pubitemid 32266068)
105. M.J. Schaaf, R.W.M. Hoetelmans, E.R. de Kloet, and E. Vreugdenhil Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus J. Neurosci. Res. 48 1997 334 341 (Pubitemid 27232707)
106. M.J.M. Schaaf, J. de Jong, E.R. de Kloet, and E. Vreugdenhil Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone Brain Res. 813 1998 112 120 (Pubitemid 29012524)
107. M.V. Schmidt, V. Sterlemann, K. Ganea, C. Liebl, S. Alam, D. Harbich, M. Greetfeld, M. Uhr, F. Holsboer, and M.B. Müller Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence Psychoneuroendocrinology 32 2007 417 429 (Pubitemid 46755998)
108. E. Shimizu, K. Hashimoto, N. Okamura, K. Koike, N. Komatsu, C. Kumakiri, M. Nakazato, H. Watanabe, N. Shinoda, S. Okada, and M. Iyo Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants Biol. Psychiatry 54 2003 70 75 (Pubitemid 36776725)
109. B.R. Shrestha, O.V. Vitolo, P. Joshi, T. Lordkipanidze, M. Shelanski, and A. Dunaevsky Amyloid b peptide adversely affects spine number and motility in hippocampal neurons Mol. Cell. Neurosci. 33 2006 274 282 (Pubitemid 44696319)
110. J.A. Siuciak, D.R. Lewis, S.J. Wiegand, and R.M. Lindsay Antidepressant-like effect of brain derived neurotrophic factor (BDNF) Pharmacol. Biochem. Behav. 56 1997 131 137 (Pubitemid 27016116)
111. L. Song, W. Che, W. Min-Wei, Y. Murakami, and K. Matsumoto Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress Pharmacol. Biochem. Behav. 83 2006 186 193
112. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening anti-depressant drugs Psychopharmacolgy (Berlin) 85 1985 367 370 (Pubitemid 15123115)
113. B. Vellas, O. Sol, P.J. Snyder, P.J. Ousset, R. Haddad, M. Maurin, J.C. Lemarié, L. Désiré, and M.P. Pando EHT0202/002 study group. EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study Curr. Alzheimer Res. 8 2011 203 212
114. S.V. Vellucci, R.F. Parrott, and M.L. Mimmack Down-regulation of BDNF mRNA, with no effect on trkB or glucocorticoid receptor mRNAs, in the porcine hippocampus after acute dexamethasone treatment Res. Vet. Sci. 70 2001 157 162 (Pubitemid 32510225)
115. E. Vermetten, M. Vythilingam, C. Schmahl, C. dE Kloet, S.M. Southwick, D.S. Charney, and J.D. Bremner Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder Ann. N.Y. Acad. Sci. 1071 2006 184 202 (Pubitemid 44126728)
116. S.A. Vreeburg, F.G. Zitman, J. van Pelt, R.H. Derijk, J.C. Verhagen, and R. van Dyck Salivary cortisol levels in persons with and without different anxiety disorders Psychosom. Med. 72 2010 340 347
117. P. Willner Validity, reability and utility of the chronic mild stress model of depression: a 10-year review and evaluation Psychopharmacology 134 1997 319 329 (Pubitemid 28023396)
118. P. Willner Chronic mild stress (CMS) revisited: consistency and behavioural- neurobiological concordance in the effects of CMS Neuropsychobiology 52 2005 90 110 (Pubitemid 41160326)
119. Y. Xu, B. Ku, L. Tie, H. Yao, W. Jiang, X. Ma, and X. Li Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB Brain Res. 1122 2006 56 64 (Pubitemid 44708120)
120. I. Yalcin, C. Belzung, and A. Surget Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey Behav. Brain Res. 193 2008 140 143
121. A. Zafir, A. Ara, and N. Banu In vivo antioxidant status: a putative target for antidepressant action Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 220 228
122. Y. Zhang, D.K. Raap, F. Garcia, F. Serres, Q. Ma, G. Battaglia, and L.D. Van de Kar Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats Brain Res. 855 2000 58 66 (Pubitemid 30067694)
123. H.T. Zhang, Y. Huang, S.L. Jin, S.A. Frith, N. Suvarna, M. Conti, and J.M. O'Donnell Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme Neuropsychopharmacology 27 2002 587 595
124. H. Zheng, Y. Liu, W. Li, B. Yang, D. Chen, X. Wang, Z. Jiang, H. Wang, Z. Wang, G. Cornelisson, and F. Halberg Beneficial effects of exercise and it molecular mechanisms on depression in rats Behav. Brain Res. 168 2006 47 55 (Pubitemid 43152052)